PentaBind valuation, funding and investors
PentaBind works in aptamer design and development, based in London, United Kingdom. Founded in 2021, it has about 15 employees.
- Last round
- Seed · Jun 2025
- Valuation at last round
- $19.0M · implied
- Headcount
- 15 · growing
- Grade
- D
- Founded
- 2021
PentaBind valuation today
VCMC values PentaBind at $40.7M today, with a range of $10.4M to $81.1M and a grade of D. The valuation starts from its last funding round, a seed round in Jun 2025.
Valuation by date (72 rows)
Each point is what the model would have shown on that date, using only what was known then; before its first round, a company is valued as a startup because it later raised.
| Date | Valuation | Range | Predicted in 1 yr | Phase | Headcount | Trend | Grade | Winding-down probability |
|---|---|---|---|---|---|---|---|---|
| 1 Jan 2021 | $10.7M | $3.89M – $29.3M | $11.9M (+11%) | before first round | – | unknown | D | 0% |
| 1 Feb 2021 | $10.8M | $3.93M – $29.6M | $12.0M (+11%) | before first round | – | unknown | D | 0% |
| 1 Mar 2021 | $10.9M | $3.96M – $29.9M | $12.1M (+11%) | before first round | – | unknown | D | 0% |
| 1 Apr 2021 | $11.0M | $3.99M – $30.1M | $12.2M (+11%) | before first round | – | unknown | D | 0% |
| 1 May 2021 | $11.1M | $4.03M – $30.4M | $12.2M (+11%) | before first round | – | unknown | D | 0% |
| 1 Jun 2021 | $11.2M | $4.07M – $30.7M | $12.3M (+10%) | before first round | – | unknown | D | 0% |
| 1 Jul 2021 | $11.3M | $4.10M – $31.0M | $12.4M (+10%) | before first round | – | unknown | D | 0% |
| 1 Aug 2021 | $11.4M | $4.14M – $31.2M | $12.5M (+10%) | before first round | – | unknown | D | 0% |
| 1 Sep 2021 | $11.5M | $4.18M – $31.5M | $12.6M (+10%) | before first round | – | unknown | D | 0% |
| 1 Oct 2021 | $11.6M | $4.22M – $31.8M | $12.7M (+10%) | before first round | – | unknown | D | 0% |
| 1 Nov 2021 | $11.7M | $4.25M – $32.1M | $12.8M (+10%) | before first round | – | unknown | D | 0% |
| 1 Dec 2021 | $11.8M | $4.29M – $32.4M | $12.9M (+9%) | before first round | – | unknown | D | 0% |
| 1 Jan 2022 | $11.9M | $4.33M – $32.7M | $13.0M (+9%) | before first round | – | unknown | D | 0% |
| 1 Feb 2022 | $12.0M | $4.36M – $32.9M | $13.1M (+9%) | before first round | – | unknown | D | 0% |
| 1 Mar 2022 | $12.1M | $4.39M – $33.2M | $13.2M (+9%) | before first round | – | unknown | D | 0% |
| 1 Apr 2022 | $12.2M | $4.43M – $33.4M | $13.3M (+9%) | before first round | – | unknown | D | 0% |
| 1 May 2022 | $12.2M | $4.46M – $33.6M | $13.4M (+9%) | before first round | – | unknown | D | 0% |
| 1 Jun 2022 | $12.3M | $4.49M – $33.9M | $13.5M (+9%) | before first round | – | unknown | D | 0% |
| 1 Jul 2022 | $12.4M | $4.53M – $34.1M | $13.6M (+9%) | before first round | – | unknown | D | 0% |
| 1 Aug 2022 | $12.5M | $4.56M – $34.4M | $13.7M (+9%) | before first round | – | unknown | D | 0% |
| 1 Sep 2022 | $12.6M | $4.59M – $34.7M | $13.8M (+9%) | before first round | – | unknown | D | 0% |
| 1 Oct 2022 | $12.7M | $4.63M – $34.9M | $13.9M (+9%) | before first round | – | unknown | D | 0% |
| 1 Nov 2022 | $12.8M | $4.66M – $35.2M | $14.0M (+9%) | before first round | – | unknown | D | 0% |
| 1 Dec 2022 | $12.9M | $4.70M – $35.4M | $14.1M (+9%) | before first round | – | unknown | D | 0% |
| 1 Jan 2023 | $13.0M | $4.73M – $35.7M | $14.2M (+9%) | before first round | – | unknown | D | 0% |
| 1 Feb 2023 | $10.5M | $3.81M – $28.8M | $11.4M (+9%) | before first round | 4 | unknown | D | 0% |
| 1 Mar 2023 | $10.5M | $3.84M – $29.0M | $11.5M (+9%) | before first round | 4 | unknown | D | 0% |
| 1 Apr 2023 | $10.6M | $3.87M – $29.2M | $11.6M (+9%) | before first round | 4 | unknown | D | 0% |
| 1 May 2023 | $10.7M | $3.90M – $29.4M | $11.7M (+9%) | before first round | 4 | unknown | D | 0% |
| 1 Jun 2023 | $10.8M | $3.93M – $29.6M | $11.8M (+9%) | before first round | 4 | unknown | D | 0% |
| 1 Jul 2023 | $10.9M | $3.95M – $29.8M | $11.9M (+9%) | before first round | 4 | unknown | D | 0% |
| 1 Aug 2023 | $10.9M | $3.98M – $30.1M | $11.9M (+8%) | before first round | 4 | unknown | D | 0% |
| 1 Sep 2023 | $11.0M | $4.01M – $30.3M | $11.9M (+8%) | before first round | 4 | unknown | D | 0% |
| 1 Oct 2023 | $11.1M | $4.04M – $30.5M | $11.9M (+7%) | before first round | 4 | unknown | D | 0% |
| 1 Nov 2023 | $10.7M | $3.89M – $29.3M | $11.3M (+6%) | before first round | 3 | unknown | D | 0% |
| 1 Dec 2023 | $10.8M | $3.92M – $29.6M | $11.3M (+5%) | before first round | 3 | unknown | D | 0% |
| 1 Jan 2024 | $10.8M | $3.95M – $29.8M | $11.3M (+5%) | before first round | 3 | unknown | D | 0% |
| 1 Feb 2024 | $10.9M | $3.98M – $30.0M | $11.3M (+4%) | before first round | 3 | unknown | D | 0% |
| 1 Mar 2024 | $11.0M | $4.00M – $30.2M | $11.3M (+3%) | before first round | 3 | unknown | D | 0% |
| 1 Apr 2024 | $11.1M | $4.03M – $30.4M | $11.3M (+2%) | before first round | 3 | unknown | D | 0% |
| 1 May 2024 | $11.2M | $4.06M – $30.7M | $11.3M (+1%) | before first round | 3 | unknown | D | 0% |
| 1 Jun 2024 | $11.2M | $4.09M – $30.9M | $11.3M (+1%) | before first round | 3 | unknown | D | 0% |
| 1 Jul 2024 | $11.3M | $4.12M – $31.1M | $11.3M (0%) | before first round | 3 | unknown | D | 0% |
| 1 Aug 2024 | $11.3M | $4.12M – $31.1M | $11.3M (0%) | before first round | 3 | unknown | D | 0% |
| 1 Sep 2024 | $12.7M | $4.61M – $34.8M | $12.7M (0%) | before first round | 6 | unknown | D | 0% |
| 1 Oct 2024 | $12.7M | $4.61M – $34.8M | $12.7M (0%) | before first round | 6 | unknown | D | 0% |
| 1 Nov 2024 | $12.7M | $4.61M – $34.8M | $12.7M (0%) | before first round | 6 | unknown | D | 0% |
| 1 Dec 2024 | $19.0M | $8.14M – $37.8M | $19.0M (0%) | before first round | 10 | growing | C | 0% |
| 1 Jan 2025 | $19.0M | $8.14M – $37.8M | $19.0M (0%) | before first round | 10 | growing | C | 0% |
| 1 Feb 2025 | $19.0M | $8.14M – $37.8M | $19.0M (0%) | before first round | 10 | growing | C | 0% |
| 1 Mar 2025 | $19.0M | $8.14M – $37.8M | $19.0M (0%) | before first round | 10 | growing | C | 0% |
| 1 Apr 2025 | $19.0M | $8.14M – $37.8M | $19.0M (0%) | before first round | 10 | growing | C | 0% |
| 1 May 2025 | $19.0M | $8.14M – $37.8M | $19.0M (0%) | before first round | 10 | growing | C | 0% |
| 1 Jun 2025 | $19.0M | $8.14M – $37.8M | $19.0M (0%) | before first round | 10 | growing | C | 0% |
| 7 Jun 2025 | $19.0M | $9.53M – $75.8M | $38.0M (+100%) | after a round | 10 | growing | D | 0% |
| 1 Jul 2025 | $19.9M | $9.53M – $75.8M | $38.0M (+91%) | after a round | 10 | growing | D | 0% |
| 1 Aug 2025 | $21.1M | $9.53M – $75.8M | $38.0M (+80%) | after a round | 11 | growing | D | 0% |
| 1 Sep 2025 | $22.4M | $9.53M – $75.8M | $38.0M (+70%) | after a round | 11 | growing | D | 0% |
| 1 Oct 2025 | $23.7M | $9.53M – $75.8M | $38.0M (+60%) | after a round | 11 | growing | D | 0% |
| 1 Nov 2025 | $25.2M | $9.53M – $75.8M | $38.0M (+51%) | after a round | 11 | growing | D | 0% |
| 1 Dec 2025 | $27.1M | $9.89M – $78.6M | $39.4M (+45%) | after a round | 13 | growing | D | 0% |
| 1 Jan 2026 | $28.8M | $9.89M – $78.6M | $39.4M (+37%) | after a round | 13 | growing | D | 0% |
| 1 Feb 2026 | $30.7M | $9.89M – $78.6M | $39.4M (+28%) | after a round | 13 | growing | D | 0% |
| 1 Mar 2026 | $32.5M | $9.89M – $78.6M | $39.4M (+21%) | after a round | 13 | up | D | 0% |
| 1 Apr 2026 | $35.0M | $10.0M – $79.9M | $40.1M (+14%) | after a round | 14 | growing | D | 0% |
| 1 May 2026 | $37.2M | $10.0M – $79.9M | $40.1M (+8%) | after a round | 14 | growing | D | 0% |
| 1 Jun 2026 | $40.2M | $10.2M – $81.1M | $40.7M (+1%) | after a round | 15 | growing | D | 0% |
| 1 Jul 2026 | $40.7M | $10.2M – $81.1M | $40.7M (0%) | after a round | 15 | growing | D | 0% |
| 1 Aug 2026 | $40.7M | $10.3M – $81.1M | $40.7M (0%) | after a round | 15 | growing | D | 0% |
| 1 Sep 2026 | $40.7M | $10.3M – $81.1M | $40.7M (0%) | after a round | 15 | growing | D | 0% |
| 1 Oct 2026 | $40.7M | $10.4M – $81.1M | $40.7M (0%) | after a round | 15 | growing | D | 0% |
| 24 Oct 2026 | $40.7M | $10.4M – $81.1M | $40.7M (0%) | after a round | 15 | growing | D | 0% |
Key facts about PentaBind
- Founded
- 2021
- Headquarters
- London, United Kingdom
- Employees
- about 15 +36% in a year
- Total raised
- Undisclosed
- Funding rounds
- 1
- Last round
- Seed Jun 2025
PentaBind was founded in 2021 by Miguel Gonzalez, Phil Haynes and Rory Ryan.
PentaBind funding history
PentaBind has 1 funding round on record, from Jun 2025 to Jun 2025. None disclosed a valuation.
Seed 6 Jun 2025
With Hoxton Ventures, Next Sequence, Twin Path Ventures, Science Entrepreneur Club.
Amount undisclosed
PentaBind investors
4 investors have backed PentaBind.
- Hoxton Ventures
- Next Sequence
- Science Entrepreneur Club
What PentaBind does
PentaBind works in biotechnology, with 14 recorded offerings and customers in biotechnology, pharmaceuticals and healthcare.
PentaBind Ltd is a UK biotechnology company engaged in the design and development of aptamers for therapeutic applications, diagnostics, and manufacturing processes. The company utilizes generative artificial intelligence and a wet laboratory platform to create nucleic acid-based therapeutics, with a focus on optimizing aptamer libraries for SELEX pipelines. PentaBind also provides aptamer evaluation, design, and SELEX analysis services, and develops proprietary technology for designing aptamers with multiple characteristics. Its operations serve organizations in the pharmaceutical and biotechnology sectors.
Description from Veridion's company data.
Products and services
- Aptamer Design and Development
- AI-Driven Aptamer Design
- Wet-Laboratory Aptamer Optimization
- Drug-Like Aptamer Discovery
- Therapeutic Asset Development
- Diagnostic Platform Development
- Manufacturing Process Optimization
- Hot-Start Polymerase Development
- Purification and Quality Control Solutions
- In-Vitro Validation Services
- Clinical Asset Advancement
- Proprietary Aptamer Dataset Utilization
- Molecular Modeling and Simulation Services
- Operational and Technical Services
Markets
- Biotechnology
- Pharmaceuticals
- Healthcare
Technology
- AI-Driven Aptamer Design
- Molecular Modeling for Aptamer Design
- Wet-Laboratory Experimental Optimization
- Sub-Nanomolar Binding Affinity Aptamers
- Tunable Stability Aptamers
- Predictable Nucleotide Sequence Aptamers
Certifications
- FDA Fast Track
Business model
- Business-to-Business
- Service Provider
- Manufacturing
Industry codes (NAICS)
- 541714 Research and Development in Biotechnology (except Nanobiotechnology) 100% match
Questions about PentaBind
What is PentaBind worth?
Valuation $40.7M (range $10.4M to $81.1M), as of 24 Oct 2026.
Has PentaBind raised money?
PentaBind has 1 funding round on record, from Jun 2025 to Jun 2025. None disclosed a valuation.
Who has invested in PentaBind?
Hoxton Ventures, Next Sequence, Science Entrepreneur Club and Twin Path Ventures.
How many people work at PentaBind?
About 15, up 36% over the last year. Headcount grew from 4 in Jan 2023 to 15 in Sep 2026.
What does PentaBind do?
PentaBind works in biotechnology, with 14 recorded offerings and customers in biotechnology, pharmaceuticals and healthcare. Its main offerings are aptamer design and development, AI-Driven aptamer design and wet-laboratory aptamer optimization.
When was PentaBind founded, and where is it based?
PentaBind was founded in 2021 and is based in London, United Kingdom. It has about 15 employees, up 36% over the last year.